Connor, Clark & Lunn Investment Management (CC&L)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.21M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $342K | Sell |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $500K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.53M | Sell |
|
|||||
|
2022
Q4 | $2.58M | Sell |
|
|||||
|
2022
Q3 | $2.27M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $654K | Sell |
|
|||||
|
2021
Q2 | $486K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $654K | Sell |
|
|||||
|
2020
Q3 | $765K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $347K | Sell |
|
|||||
|
2018
Q2 | $453K | Buy |
|
|||||
|
2018
Q1 | $1.64M | Buy |
|
|||||
|
2017
Q4 | $1.52M | Sell |
|
|||||
|
2017
Q3 | $1.54M | Buy |
|
|||||
|
2017
Q2 | $1.28M | Buy |
|
|||||
|
2017
Q1 | $302K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $577K | Sell |
|
|||||
|
2014
Q4 | $458K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2.29M | Buy |
|
|||||
|
2013
Q4 | $2.39M | Sell |
|
|||||
|
2013
Q3 | $3.42M | Buy |
|
|||||
|
2013
Q2 | $1.04M | Buy |
|